Organic isocyanates are used in the manufacture of flexible and rigid foams, synthetic rubbers, adhesives, and paints. The isocyanates involved are toluene diisocyanate (TDI), diphenyl-methane diisocyanate (MDI), naphthylene diisocyanate (NDI) , and hexamethylene diisocyanate (HDI). TDI is the most widely used.
Organic isocyanate vapour has been known for many years to produce irritation of the skin, eyes, and bronchial tree and also to produce sensitization resulting in bronchospasm which is often delayed some hours after exposure (Fuchs and Valade, 1951; Woodbury, 1956; Trenchard and Harris, 1963; Silver, 1963; Dodson, 1966) . It also seems probable that long-term exposure to low concentrations, below the recommended threshold limit value of 0 02 ppm, may produce chronic airways obstruction (Adams, 1970; Hill, 1970; Peters, 1970) .
In the large majority of reported cases of isocyanate toxicity, chest radiographs have been normal. However, Blake et al. (1965) described four patients in whom pulmonary opacities developed after isocyanate exposure. This paper describes four patients who presented with dyspnoea after exposure to isocyanates, and in whom evidence of interstitial rather than bronchial disease was found. Challenge experiments in rabbits were carried out in an attempt to reproduce the disease, and these results are also described.
METHODS
PATIENTS Four patients were studied. Three worked in factories using TDI in the manufacture of polyurethane foam and were therefore exposed to low levels of TDI. Two of these were known to have been exposed to large 'spills' of TDI, one on three occasions. The fourth patient had used a polyurethane paint, thought to contain a low percentage of HDI, for six months.
PULMONARY FUNCTION Forced expiratory volume in one second (FEVy) and vital capacity (VC) were determined using a dry spirometer, the residual volume (RV) , functional residual capacity (FRC), and total lung capacity (TLC) by the closed-circuit helium dilution method, and the 127 gas transfer factor by the single-breath carbon monoxide technique. Static compliance was measured in the seated position using a Godard pneumotachograph with integrator for volume while oesophageal pressures were taken from a balloon sited in the lower third of the oesophagus and measured with a differential pressure transducer. Predicted values were those of Cotes (1968) . IMMUNOLOGY In case 1, TDI-albumin (prepared by the method of Scheel, Killens, and Josephson (1964) ) was used to identify precipitating antibodies (Ouchterlony, 1953) and haemagglutinating antibodies using formalinized sheep red blood cells (Boyden, 1951) . Precipitating antibodies to a range of common antigens were also sought. Skin testing was carried out in this patient and one control with 0-1 ml of TDI-albumin, 1 mg/ml intradermally. New Zealand white rabbits, aged 9-12 months, were sensitized to TDI-albumin by a series of intramuscular injections given twice a week over a period of three weeks, starting with 05 ml of antigen in adjuvant and increasing the dose to 2-0 ml. Ten rabbits were similarly sensitized to albumin. Serology Rabbits were bled one week after the final sensitizing dose, and sera were examined for the presence of precipitating antibodies by agar gel double diffusion (Ouchterlony, 1953) ; complement fixation tests (Bradstreet and Taylor, 1962) were also performed. Quantitative precipitin curves (Kabat, 1961) were obtained by incubating 0, 2, 4, 6, 8, and 10 mg of TDI-albumin conjugate with 1 ml aliquots of either TDIalbumin or albumin antiserum at 37°C for 2 hours and at 4°C overnight. Similarly, precipitin curves were obtained with albumin antigen and both TDI-albumin and albumin antisera. The precipitates were collected, washed with saline, and dissolved in 0-0IM NaOH, and protein concentrations were determined by spectrophotometry at 280 mt, using an absorption value of 13 6 for a 1% solution of y globulin (Rowe and Fahey, 1965) . Skin Testing Skin tests were performed on four of the rabbits sensitized to TDI-albumin. An area on the hind leg was shaved and 0 2 ml of TDIalbumin '(1 mg ml--'), albumin (1 mg ml-1), and saline were introduced intradermally. Control tests were performed on two unsensitized rabbits. Challenge Two weeks after the final sensitizing dose rabbits were challenged by endotracheal deposition of antigen while under pentobarbitone sodium (Nembutal) anaesthesia.
Eight rabbits sensitized to TDI-albumin received 0-5 ml of the same antigen at 10 mg ml-1 and two received 0 5 ml of saline. Of the rabbits sensitized to egg-albumin, two were challenged endotracheally with 05 ml of albumin at 10 mg ml 1 and two with TDI-albumin; further unsensitized control rabbits were challenged endotracheally with 0 5 ml of saline, TDI-albumin, and albumin.
All rabbits were killed by a rapid intravenous injection of pentobarbitone sodium either 18 hours or six days after challenge. Lungs were removed immediately after death, inflated, and fixed with formalin, sectioned on the microtome, and stained with haematoxylin and eosin, alcian blue or periodic acid Schiff. CASE REPORTS CASE 1 A 50-year-old non-smoking man had worked for five years on a polyurethane foam process. He had previously been a coalminer for 11 years. In May 1968 he was admitted to hospital with a six-week history of dyspnoea, weight loss, and fever. He had no cough, sputum or wheezing. He was tachypnoeic, and chest radiographs showed an alveolar filling lesion, confluent in the left lung and in the right mid zone (Fig. 1) . Previous radiographs, though said to be normal, were unobtainable. Sputum showed a growth of Haemophilus influenzae of doubtful significance. Repeated cultures failed to grow Aspergillus, and hyphae were never seen in fresh specimens. After treatment with antibiotics there was partial radiological resolution and he was discharged. Two months later he remained dyspnoeic and the radiograph then showed shadowing in the right lower zone (Fig. 2) . Pulmonary function testing showed a restrictive ventilatory defect and a reduced transfer factor (Table) . A bronchogram showed peripheral cystic bronchiectasis in the (Fig. 5) . In other areas alveolar spaces were filled with large mononuclear cells, an appearance similar to that of desquamative interstitial pneumonitis of Liebow (Fig. 6) . Other features were a heavy infiltrate of eosinophilic polymorphonuclear cells in interalveolar septa and contributing to intra-alveolar cellular exudate (Fig. 7) ; areas of protein-rich i oedema and lymphocytic foci were also present. dyspnoea. After his return to work in a different department, but still in fairly close proximity to TDI in low concentration, the dyspnoea recurred after a few days and he has not worked since that time, complaining of severe dyspnoea, without wheezing, on slight exertion. There was no past nor family history of chest disease or allergy. There was no blood nor sputum eosinophilia and all chest radiographs have been normal. In July 1966 his VC was 31% of predicted. More complete pulmonary function studies were carried out in September 1969 (Table) and showed a restrictive pattern with low compliance and transfer factor and moderate airways obstruction. PATHOLOGY Unsensitized rabbits receiving the TDI-albumin antigen developed mainly interstitial lung changes with some migration of neutrophils and a few foamy macrophages; alveolar capillaries were congested. Patchy interstitial changes were also seen in sensitized rabbits after challenge with TDI-albumin. There was marked migration of neutrophils through thickened pulmonary arteries and oedema in peribronchial lymphoid tissue. Six days after challenging sensitized rabbits with TDI-albumin there were extensive areas of consolidation with necrosis, and in the parenchyma between necrotic areas were interstitial inflammatory changes, pulmonary oedema, epithelial metaplasia, some vasculitis (thickening of arterial walls and endothelial neutrophil cuffing), and in places epithelioid giantcell accumulations around irregularly shaped eosinophilic material. Also observed were a few residual bronchiolar lesions with neutrophils still present, residual peribronchial lymphoid hyperplasia, and a few loose collections of macrophages. Sensitized rabbits receiving the TDI-albumin antigen also developed increases in the number of goblet cells on the bronchial and bronchiolar intima, goblet-cell hyperplasia being more marked 6 days rather than 18 hours after challenge. No goblet cell hyperplasia was seen in unsensitized rabbits challenged with TDI-albumin.
Lungs of control rabbits sensitized by either TDI-albumin or albumin and challenged endotracheally with saline were noticeably undamaged. Further control rabbits sensitized and challenged with albumin produced lesions of a different nature from those obtained with TDI-albumin, interstitial pneumonitis with thickening of alveolar septa and slight alveolar exudation of large mononuclear cells being the major lesions observed.
DISCUSSION
Isocyanates are strongly irritant substances which in practice mainly affect the respiratory system. The majority of previous reports have pointed out the ability of inhaled isocyanates to produce airways obstruction (Fuchs and Valade, 1951; Trenchard and Harris, 1963) . Some of these cases appeared to follow exposure to relatively high concentrations (Woodbury, 1956) while in others the reactions occurred after exposure to very low concentrations (Brugsch and Elkins, 1963; Silver, 1963; Dodson, 1966) . In the cases with heavy exposure it is conceivable that a chemical irritant effect on the bronchi produced mucosal oedema and bronchospasm, but when previously exposed workers develop wheezing within seconds of being exposed to low concentrations it is considered that a hypersensitivity mechanism must also be involved.
In animals it has been shown that injection of TDI-protein conjugates results in a circulating antibody directed against the TDI determinant (Scheel et al., 1964) . These workers also showed a circulating antibody response in rabbits to prolonged inhalation of TDI vapour. We have used the same methods in our rabbit experiments with similar results. Whether the antibodies found are due specifically to TDI or to TDI-denatured protein cannot be determined from these experiments. Stevens and Palmer (1970) investigated the effect of exposure of guinea-pigs and rhesus monkeys to atmospheres of TDI at various concentrations. They did not find an allergic mechanism to explain the sensitivity of the respiratory system and they concluded that the value of investigative work in this field was greatly limited by the complex analytical problems encountered with TDI atmospheres. Bruckner et al. (1968) showed evidence of sensitization in man by demonstrating lymphocyte transformation in sensitized individuals induced by TDI-human serum albumin conjugate. Taylor (1970) demonstrated that exposure to TDI vapour may give rise to circulating antibodies in man, but the aetiological relationship between these and symptoms of clinical sensitivity remains to be investigated.
There has been one report of pulmonary opacities resulting from diisocyanate exposure (Blake et al., 1965 ): four cases were described of dyspnoea and cough following exposure to TDI with changes of consolidation on the chest radiographs. Details of pulmonary function are not given. Each patient improved on complete removal from exposure, one relapsing on re-exposure.
Our four cases are the first described to have developed impairment of respiratory function other than airways obstruction after isocyanate exposure. This potentially more serious lesion of interstitial pneumonitis occurred in two after heavy exposure but in two after much lighter exposure, and in all patients symptoms and physiological evidence of disease persisted after removal from other than 'neighbourhood' exposure. The likelihood that the disease in these patients was due to isocyanates is supported by the detailed histological evidence suggesting inhalational allergic pneumonitis in case 1 and its similarity to that induced experimentally by challenge in animals. Moreover, all our patients also had the more usual pattern of airways obstruction, suggesting that both the bronchi and the interstitial tissues were involved, a feature seen in other conditions grouped as allergic alveolitis. However the difficulty of being certain of the diagnosis clinically is shown by the negative immunological tests in case 1 and the normal radiographs in the other patients.
Rabbits sensitized to produce precipitating antibodies against TDI-albumin and challenged with the same antigen developed lesions similar in nature to those observed in rabbits after the production of a type III response by consecutive endotracheal depositions of heterologous serum (Edwards, 1974 al., 1965) and high (Duncan et al., 1962) concentrations of TDI. Direct chemical injury was thought to be responsible but since gobletcell hyperplasia was observed to a much lesser degree in unsensitized rabbits challenged with TDI-albumin it seems possible that an immune mechanism may be involved in the production of this lesion. Our animal results therefore raise the question whether pulmonary hypersensitivity reactions themselves may result in permanent hyperplasia of mucus-secreting apparatus and lead to clinical chronic bronchitis in man. The TDI-albumin antigen used experimentally is unlikely to be the same as that produced in the body by combination between TDI vapour and body proteins. It is considered more likely that TDI reacts with protein of the mouth, nose, and upper respiratory tract and that particles of conjugated protein are then inhaled. Whether such an 'antigen' would produce lesions in the lung similar to those obtained with TDI-albumin conjugate requires further study. There were no eosinophilic responses or immediately positive skin tests in the experimental animals and it therefore seems unlikely that type I mediated reactions to TDI-albumin conjugate occurred in these. Type I allergy to TDI may, of course, be confined to the human species.
One should be cautious in comparing the experimental situation with that in patients because of species differences, unnatural antigen conjugates, and dosage differences. We have, however, shown evidence of a type III response to challenge in sensitized rabbits and also that lesions other than bronchial can occur in man following exposure to isocyanates. We postulate that isocyanate inhalation in some situations may give rise to a type III immune response in man which may produce interstitial lung disease.
Isocyanate workers are at present routinely examined for evidence of airways obstruction. If their lung volumes and gas transfer factors were also measured it is possible that more cases such as ours would be found, and that some of these patients may be helped by corticosteroids.
